Search by Drug Name or NDC

    NDC 51991-0797-98 Azacitidine 100 mg/50mL Details

    Azacitidine 100 mg/50mL

    Azacitidine is a SUBCUTANEOUS INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Breckenridge Pharmaceutical, Inc.. The primary component is AZACITIDINE.

    Product Information

    NDC 51991-0797
    Product ID 51991-797_1ba11f6a-c960-4e56-9f71-fdc972d990db
    Associated GPIs 21300003001920
    GCN Sequence Number 054660
    GCN Sequence Number Description azacitidine VIAL 100 MG INJECTION
    HIC3 V1B
    HIC3 Description ANTINEOPLASTIC - ANTIMETABOLITES
    GCN 22663
    HICL Sequence Number 026361
    HICL Sequence Number Description AZACITIDINE
    Brand/Generic Generic
    Proprietary Name Azacitidine
    Proprietary Name Suffix n/a
    Non-Proprietary Name Azacitidine
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
    Route SUBCUTANEOUS
    Active Ingredient Strength 100
    Active Ingredient Units mg/50mL
    Substance Name AZACITIDINE
    Labeler Name Breckenridge Pharmaceutical, Inc.
    Pharmaceutical Class Nucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA207234
    Listing Certified Through n/a

    Package

    NDC 51991-0797-98 (51991079798)

    NDC Package Code 51991-797-98
    Billing NDC 51991079798
    Package 1 VIAL, SINGLE-DOSE in 1 CARTON (51991-797-98) / 50 mL in 1 VIAL, SINGLE-DOSE
    Marketing Start Date 2017-08-07
    NDC Exclude Flag N
    Pricing Information N/A